<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31338352</article-id>
<article-id pub-id-type="pmc">6628938</article-id>
<article-id pub-id-type="doi">10.3389/fped.2019.00270</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Novel 3q29 Deletion in Association With Developmental Delay and Heart Malformation—Case Report With Literature Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chirita Emandi</surname>
<given-names>Adela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/688249/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dobrescu</surname>
<given-names>Andreea Iulia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doros</surname>
<given-names>Gabriela</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hyon</surname>
<given-names>Capucine</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miclea</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Popoiu</surname>
<given-names>Calin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Puiu</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/115626/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arghirescu</surname>
<given-names>Smaranda</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Discipline of Genetics, Victor Babeș University of Medicine and Pharmacy</institution>, <addr-line>Timișoara</addr-line>, <country>Romania</country></aff>
<aff id="aff2"><sup>2</sup><institution>“Louis Turcanu” Clinical Emergency Hospital for Children</institution>, <addr-line>Timișoara</addr-line>, <country>Romania</country></aff>
<aff id="aff3"><sup>3</sup><institution>IIIrd Pediatric Clinic, Pediatric Cardiology, Victor Babeș University of Medicine and Pharmacy</institution>, <addr-line>Timișoara</addr-line>, <country>Romania</country></aff>
<aff id="aff4"><sup>4</sup><institution>Département de Génétique Médicale, AP-HP, GHUEP, Hôpital Armand Trousseau</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff5"><sup>5</sup><institution>INSERM, UMRS 933, Hôpital Armand Trousseau</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff6"><sup>6</sup><institution>Sorbonne Universités, UPMC Univ Paris 06</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff7"><sup>7</sup><institution>Genetics Department Cluj-Napoca, Iuliu Hațieganu University of Medicine and Pharmacy</institution>, <addr-line>Cluj-Napoca</addr-line>, <country>Romania</country></aff>
<aff id="aff8"><sup>8</sup><institution>Discipline of Pediatric Surgery, Victor Babeș University of Medicine and Pharmacy</institution>, <addr-line>Timișoara</addr-line>, <country>Romania</country></aff>
<aff id="aff9"><sup>9</sup><institution>IIIrd Pediatric Clinic, Victor Babeș University of Medicine and Pharmacy</institution>, <addr-line>Timișoara</addr-line>, <country>Romania</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Merlin G. Butler, University of Kansas Medical Center, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Fan Jin, Zhejiang University, China; Feodora Stipoljev, University Hospital Sveti Duh, Croatia</p>
</fn>
<corresp id="c001">*Correspondence: Adela Chirita Emandi <email>adela.chirita@umft.ro</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Genetic Disorders, a section of the journal Frontiers in Pediatrics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>7</volume>
<elocation-id>270</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Chirita Emandi, Dobrescu, Doros, Hyon, Miclea, Popoiu, Puiu and Arghirescu.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Chirita Emandi, Dobrescu, Doros, Hyon, Miclea, Popoiu, Puiu and Arghirescu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>3q29 deletion syndrome is a rare disorder, causing a complex phenotype. Clinical features are variable and relatively non-specific. Our report aims to present an atypical, <italic>de novo</italic> deletion in chromosome band 3q29 in a preschool boy, first child of healthy non-consanguineous parents, presenting a particular phenotype (microcephaly, “full moon” face, flattened facial profile, large ears, auricular polyp, and dental dystrophies), motor and cognitive delay, characteristics of autism spectrum disorder and aggressive behavior. He also presented intrauterine growth restriction (birth weight 2,400 g) and a ventricular septal defect. SNP Array revealed a 962 kb copy number loss, on the chromosome 3q29 band (195519857–196482211), consistent with 3q29 microdeletion syndrome. FISH analysis using a RP11-252K11 probe confirmed the deletion in the proband, which was not present in the parents. Although the patient's deletion is relatively small, it partly overlaps the canonical 3q29 deletion (defined between <italic>TFRC</italic> and <italic>DLG1</italic> gene) and extends upstream, associating a different facial phenotype compared to the classic 3q29 deletion, nonetheless showing a similar psychiatric disorder. This deletion is different from the canonical region, as it does not include the <italic>PAK2</italic> and <italic>DLG1</italic> genes, considered as candidates for causing intellectual disability. Thus, narrowing the genotype-phenotype correlation for the 3q29 band, <italic>FBX045</italic> is suggested as a candidate gene for the neuropsychiatric phenotype.</p>
</abstract>
<kwd-group>
<kwd>3q29</kwd>
<kwd>cytogenetics</kwd>
<kwd>intellectual disability</kwd>
<kwd>cardiac malformation</kwd>
<kwd>behavior</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Autoritatea Natională pentru Cercetare Stiintifică<named-content content-type="fundref-id">10.13039/501100005802</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="21"></ref-count>
<page-count count="7"></page-count>
<word-count count="4125"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Established Facts and Novel Insights</title>
<sec>
<title>Established Facts</title>
<list list-type="simple">
<list-item>
<p>- 3q29 deletion syndrome is characterized by a variable clinical presentation, with mild to moderate intellectual disability, autism, gait ataxia, microcephaly, cleft lip and palate, chest wall deformity.</p>
</list-item>
<list-item>
<p>- Affected people also show psychiatric disturbances, including aggression, anxiety, hyperactivity, and bipolar disorder with psychosis.</p>
</list-item>
<list-item>
<p>- Cardiac malformations, were reported in 11/42 of people with 3q29 del.</p>
</list-item>
</list>
</sec>
<sec>
<title>Novel Insights</title>
<list list-type="simple">
<list-item>
<p>- We report a <italic>de novo</italic> small deletion (&lt;1Mb) on 3q29 in a patient with microcephaly, moon face, flat profile, global developmental delay, aggressive behavior, and ventricular septal defect.</p>
</list-item>
<list-item>
<p>- This cardiac malformation was reported previously in only two cases.</p>
</list-item>
<list-item>
<p>- This deletion is different from the canonical region, as it does not include the <italic>PAK2</italic> and <italic>DLG1</italic> genes, considered as candidates causing intellectual disability; thus, narrowing the genotype-phenotype correlation for the 3q29 band.</p>
</list-item>
<list-item>
<p>- <italic>FBX045</italic> is suggested as a candidate gene for the neuropsychiatric phenotype.</p>
</list-item>
</list>
</sec>
</sec>
<sec id="s2" sec-type="intro">
<title>Introduction</title>
<p>Rare diseases are complex pathologies that require a multidisciplinary team and a very rigorous clinical evaluation. Some have a distinct, nonetheless, non-specific phenotype that makes the clinical diagnosis difficult. 3q29 deletion syndrome is a rare condition, reported in 2001 (<xref ref-type="bibr" rid="B1">1</xref>) and characterized by a variable clinical presentation, with mild to moderate intellectual disability, autism, gait ataxia, a chest wall deformity and additional features, including microcephaly, cleft lip and palate, horseshoe kidney and hypospadias observed in very few patients. Congenital anomalies associated with this condition are cardio-vascular defects, gastrointestinal abnormalities, failure to thrive, and teeth abnormalities (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>The canonical deleted region (1.6 Mb) includes several genes (~22 genes) with important roles in brain and neurocognitive development (<xref ref-type="bibr" rid="B3">3</xref>). From those, <italic>PAK2</italic> and <italic>DLG1</italic> genes were considered as candidates for causing intellectual disability. The chromosome 3q29 band was identified as a risk factor for schizophrenia, autism, bipolar disorders (<xref ref-type="bibr" rid="B4">4</xref>), and other neuropsychiatric pathologies; however, the phenotype is not clearly defined (<xref ref-type="bibr" rid="B4">4</xref>–<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>3q29 deletion syndrome has an autosomal dominant transmission. The deletion is frequently associated with segregation of neuropsychiatric diseases in families (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). The deletion presents with a variable phenotype; however, the neurocognitive abnormalities are presented in most patients (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>We aim to present a case of atypical 3q29 deletion syndrome with a particular phenotype and intellectual disability in order to further refine the genotype phenotype relation.</p>
</sec>
<sec id="s3">
<title>Clinical Presentation and Family History</title>
<p>The patient was born at 40 weeks of gestation, with a weight of 2,400 g, the first born from healthy non-consanguineous parents. The parents had normal intelligence and no reported behavioral issues. The patient's family history was unremarkable.</p>
<p>At 7 years of age, the patient had a particular phenotype (<xref ref-type="fig" rid="F1">Figure 1</xref>) with a “full moon” face, strabismus, antimongoloid slants, flattened facial profile, deviated septum, long philtrum, microretrognathia, dental dystrophies, high palate, large ears, auricular polyp, and a nasally voice. His body mass index was 19.3 kg/m<sup>2</sup> (+2 standard deviations-SD) showing obesity. His height was 122.5 cm (+1 SD), within the normal range for boys at this age. At the age of 7 years he presented waddling gait and was not able to run. The clinical presentation of the patient in comparison to others reported in a 3q29 deletion registry (<xref ref-type="bibr" rid="B5">5</xref>), is presented in <xref ref-type="table" rid="T1">Table 1</xref>. The registry has the largest reported cohort in literature with 3q29 deletion.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Patient face and profile at the age of 7 years.</p>
</caption>
<graphic xlink:href="fped-07-00270-g0001"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Clinical presentation of patient in comparison to phenotypic features, reported in a registry for 3q29 deletion (<xref ref-type="bibr" rid="B5">5</xref>) or by the literature review from Cox and Butler (<xref ref-type="bibr" rid="B6">6</xref>), arranged by decreasing frequency.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Clinical feature</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Previous reported % (no. with feature/total no. people)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Present case</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>NEUROPSICHIATRIC DEVELOPMENT (</bold>
<xref ref-type="bibr" rid="B5">
<bold>5</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Learning disability</td>
<td align="left" colspan="1" rowspan="1" valign="top">98% (41/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Speech delay</td>
<td align="left" colspan="1" rowspan="1" valign="top">59% (25/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Psychiatric disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">28% (12/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism/autistic features</td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (11/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Anxiety disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">19% (8/42)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>CRANIO-FACIAL DYSMORPHISM (</bold>
<xref ref-type="bibr" rid="B6">
<bold>6</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">High nasal bridge</td>
<td align="left" colspan="1" rowspan="1" valign="top">72% (26/36)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ocular abnormalities</td>
<td align="left" colspan="1" rowspan="1" valign="top">58% (11/19)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Microcephaly</td>
<td align="left" colspan="1" rowspan="1" valign="top">55% (18/55)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Short philtrum</td>
<td align="left" colspan="1" rowspan="1" valign="top">51% (18/35)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Low-set, posteriorly rotated ears</td>
<td align="left" colspan="1" rowspan="1" valign="top">43% (15/35)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prominent or broad nasal tip/nose</td>
<td align="left" colspan="1" rowspan="1" valign="top">40% (10/25)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Long narrow face</td>
<td align="left" colspan="1" rowspan="1" valign="top">34% (12/35)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">High-arched palate</td>
<td align="left" colspan="1" rowspan="1" valign="top">33% (12/36)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Thin upper lip</td>
<td align="left" colspan="1" rowspan="1" valign="top">30% (7/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Micrognathia</td>
<td align="left" colspan="1" rowspan="1" valign="top">29% (7/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal brain MRI/CT</td>
<td align="left" colspan="1" rowspan="1" valign="top">27% (3/11)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Brachycephaly</td>
<td align="left" colspan="1" rowspan="1" valign="top">23% (6/26)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal bossing</td>
<td align="left" colspan="1" rowspan="1" valign="top">17% (4/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Facial asymmetry</td>
<td align="left" colspan="1" rowspan="1" valign="top">17% (4/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Down-slanting palpebral fissures</td>
<td align="left" colspan="1" rowspan="1" valign="top">17% (4/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Smooth philtrum</td>
<td align="left" colspan="1" rowspan="1" valign="top">17% (4/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cup-shaped ears</td>
<td align="left" colspan="1" rowspan="1" valign="top">13% (3/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Large protruding ears</td>
<td align="left" colspan="1" rowspan="1" valign="top">9% (2/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Broad nostrils</td>
<td align="left" colspan="1" rowspan="1" valign="top">9% (2/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Long philtrum</td>
<td align="left" colspan="1" rowspan="1" valign="top">9% (2/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cleft lip/palate/submucous cleft</td>
<td align="left" colspan="1" rowspan="1" valign="top">9% (3/32)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Up slanting palpebral fissures</td>
<td align="left" colspan="1" rowspan="1" valign="top">8% (2/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>MUSCULOSKELETAL ABNORMALITIES (</bold>
<xref ref-type="bibr" rid="B6">
<bold>6</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Long/tapered fingers</td>
<td align="left" colspan="1" rowspan="1" valign="top">37% (11/30)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Clinodactylous toes</td>
<td align="left" colspan="1" rowspan="1" valign="top">32% (7/22)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chest cavity deformity</td>
<td align="left" colspan="1" rowspan="1" valign="top">29% (10/35)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Scoliosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">28% (5/18)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">5th finger clinodactyly</td>
<td align="left" colspan="1" rowspan="1" valign="top">19% (5/27)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Joint contractures</td>
<td align="left" colspan="1" rowspan="1" valign="top">19% (4/21)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal palmar crease</td>
<td align="left" colspan="1" rowspan="1" valign="top">17% (4/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ligamentous laxity</td>
<td align="left" colspan="1" rowspan="1" valign="top">11% (4/35)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Toe syndactyly</td>
<td align="left" colspan="1" rowspan="1" valign="top">9% (2/23)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>GASTROINTESTINAL ABNORMALITIES (</bold>
<xref ref-type="bibr" rid="B5">
<bold>5</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gastroesophageal reflux disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">43% (16/41)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Constipation</td>
<td align="left" colspan="1" rowspan="1" valign="top">39% (9/41)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>GENITOURINARY DEFECTS (</bold>
<xref ref-type="bibr" rid="B6">
<bold>6</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hypospadias</td>
<td align="left" colspan="1" rowspan="1" valign="top">21% (3/14)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Horseshoe kidney</td>
<td align="left" colspan="1" rowspan="1" valign="top">10% (2/21)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>OTHER FEATURES (</bold>
<xref ref-type="bibr" rid="B5">
<bold>5</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal teeth</td>
<td align="left" colspan="1" rowspan="1" valign="top">66% (28/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Failure to thrive</td>
<td align="left" colspan="1" rowspan="1" valign="top">39% (17/39)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Recurrent middle ear infections</td>
<td align="left" colspan="1" rowspan="1" valign="top">32% (13/41)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Heart defects (PDA, ASD, and others)</td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (11/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bdbec1" valign="top">
<bold>OTHER FEATURES (</bold>
<xref ref-type="bibr" rid="B6">
<bold>6</bold>
</xref>
<bold>)</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Delayed walking</td>
<td align="left" colspan="1" rowspan="1" valign="top">41% (14/34)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Low birth weight (&lt;3rd percentile)</td>
<td align="left" colspan="1" rowspan="1" valign="top">33% (10/30)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia gait/gait abnormality</td>
<td align="left" colspan="1" rowspan="1" valign="top">38% (6/24)</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Short stature</td>
<td align="left" colspan="1" rowspan="1" valign="top">24% (7/29)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal skin pigmentation</td>
<td align="left" colspan="1" rowspan="1" valign="top">14% (3/22)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>PDA, patent ductus arteriosum; ASD, atrial septal defect; No., number</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>The patient presented intellectual disability. At the age of 7 years, the patient's psychological development was comparable to that of a 2, 5 years old child. Additionally, he presented aggressive, sometimes uninhibited behavior and poor eye contact. Communication abilities included only hand gestures, and no words. He could interact with a mobile phone. The patient presented various anxieties (including a fear of dogs and stairs). He attended a normal kindergarten for 6 months, however, could not cope and thus, later attended services offered by a specialized center for intellectual disabilities.</p>
<p>His personal history showed delayed motor milestones. He started to walk around the age of 3 years and acquisitioned sphincter control after the age of 4 years. The history of illness included failure to thrive in the first 2 years, chronic constipation and repeated upper respiratory infections. He received treatment with Risperidone for his behavior, which showed a moderate response. Cardiologic evaluation at the age of 5 years, diagnosed the spontaneously closed ventricular septal defect.</p>
<p>The patient's imagistic brain evaluation, using MRI at 7 years of age was normal. Repeated EEG evaluations did not show significant changes.</p>
</sec>
<sec id="s4" sec-type="methods">
<title>Methodology</title>
<sec>
<title>Clinical Evaluation</title>
<p>The patient was evaluated by clinical geneticists along with a multidisciplinary team. The mother completed a parent-report questionnaire (The Children Behavior Check List-CBCL) in order to evaluate her perception about the child's neuropsychiatric development.</p>
<p>The parents provided written informed consent to publish this case (including publication of images).</p>
</sec>
<sec>
<title>Molecular Analyses</title>
<p>The genetic laboratory tests performed inlcuded: cytogenetic analysis (classic karyotype), SNP array using Infinium® OmniExpress-24 v1.2 Kit, ~710,000 Markers (scan performed using Iscan Illumina and GenomeStudio v2.0 software) and FISH analysis for patient and parents using the RP11-252K11 probe (localized to chr3:195907410-196071593 on build hg19, includes the <italic>ZDHHC19, PCYT1A, SLC51A, TCTEX1D2</italic>, and <italic>TM4SF19</italic> genes).</p>
<p>The patient has a normal male karyotype (46, XY). SNP array identified a 962 kb copy number loss of chromosome 3q29, between 195519857 and 196482211 (<xref ref-type="fig" rid="F2">Figure 2</xref>). That region includes the following morbid genes <italic>TFRC, PCYT1A, RNF168, TCTEX1D2</italic>, and <italic>CEP19</italic>. Non-morbid genes included in the deleted region are: <italic>TNK2, ZDHHC19, SLC51A, TM4SF19, UBXN7, RNF168, SMCO1, WDR53, FBXO45, PIGX</italic>, and <italic>NRROS</italic>. The identified copy number variation was associated with 3q29 Microdeletion syndrome (OMIM <ext-link ext-link-type="Omim" xlink:href="609425">609425</ext-link>). No other significant genomic imbalances were detected. The 3q29 deletion was confirmed in the patient by FISH analysis using a RP11-252K11 probe. The parental genetic evaluation using the same FISH probe, was negative, thus, showing a <italic>de novo</italic> origin of the deletion. The FISH analysis in the parents cannot exclude small deletion/duplication/insertion in the targeting region. Gonadal mosaicism cannot be excluded and was considered in genetic counseling.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>The 0.96-Mb deletion in the 3q29 band, arr[GRCh37] 3q29(195519857_196482211)x1 detected by whole genome SNP-array analysis and ideogram of chromosome 3. Morbid genes are depicted in red for the 3q29 band.</p>
</caption>
<graphic xlink:href="fped-07-00270-g0002"></graphic>
</fig>
<p>A systematic literature search for similar reports was performed to have an overview of genotype and phenotype syndrome aspects. The findings are presented in <xref ref-type="fig" rid="F3">Figure 3</xref> (ideogram) and <xref ref-type="table" rid="T2">Table 2</xref> (deleted limits).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Ideogram of chromosome 3 with zoomed-in details of the 3q29 band shown with a schematic view of the genes involved in the deletion. Horizontal lines in blue show proportional representation of deletion size in our patient and previously reported deletions in other patients (in order of publication year). Deletion limits were converted to GRCh37/hg19 reference (also shown in <xref ref-type="table" rid="T2">Table 2</xref>). The ideogram included the deletions reported in the literature which were detected by array. Cases reported using the FISH method were not included.</p>
</caption>
<graphic xlink:href="fped-07-00270-g0003"></graphic>
</fig>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Deletion limits reported in literature using array platforms illustrated in <xref ref-type="fig" rid="F3">Figure 3</xref>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top"><bold>Deletion limits</bold>
<italic><bold>GRCh37/hg19</bold></italic></th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Start</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>End</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Size Mb</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 1 and 2 (<xref ref-type="bibr" rid="B7">7</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,777,965</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,310,451</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.532</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 1 (<xref ref-type="bibr" rid="B2">2</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,710,112</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,338,701</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.629</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 2 (<xref ref-type="bibr" rid="B2">2</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,455,944</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,558,893</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.103</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">One patient (<xref ref-type="bibr" rid="B8">8</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,771,743</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,085,623</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.314</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 1 &amp; 2 (<xref ref-type="bibr" rid="B9">9</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,689,972</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,358,134</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.668</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 3 (<xref ref-type="bibr" rid="B9">9</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,601,025</td>
<td align="center" colspan="1" rowspan="1" valign="top">196,732,851</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.132</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">One patient (<xref ref-type="bibr" rid="B10">10</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,740,402</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,320,103</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.580</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 1 (<xref ref-type="bibr" rid="B11">11</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,740,357</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,310,392</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.570</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 2 (<xref ref-type="bibr" rid="B11">11</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,731,956</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,339,270</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.607</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 4 (<xref ref-type="bibr" rid="B11">11</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,747,856</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,339,270</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.591</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">One patient (<xref ref-type="bibr" rid="B6">6</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,788,299</td>
<td align="center" colspan="1" rowspan="1" valign="top">197,033,296</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.245</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">One patient and 6 family members (<xref ref-type="bibr" rid="B12">12</xref>)</td>
<td align="center" colspan="1" rowspan="1" valign="top">193,046,853</td>
<td align="center" colspan="1" rowspan="1" valign="top">194,407,385</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.360</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Our patient</td>
<td align="center" colspan="1" rowspan="1" valign="top">195,519,857</td>
<td align="center" colspan="1" rowspan="1" valign="top">196,482,211</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.962</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Discussion</title>
<p>Described initially as a 1.6 Mb deletion on THE long arm of chromosome 3 (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B3">3</xref>), the 3q29 deletion syndrome was defined as a recurrent subtelomeric deletion (hg 19 coordinates 195,788,299–197,033,296) between <italic>TFRC</italic> and <italic>DLG1</italic> genes (<xref ref-type="bibr" rid="B6">6</xref>). Authors described families with 3q29 syndrome in several generations (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B13">13</xref>). However, the present case is <italic>de novo</italic>, his parents do not present similar clinical or molecular abnormalities. The family history is not relevant for neuropsychiatric disorders.</p>
<p>The syndrome phenotype varies, from mild to severe, without very specific facial characteristics. Intellectual disability and psychiatric disorders are the most consistent findings (<xref ref-type="bibr" rid="B2">2</xref>). Glassford MR and collaborators have developed an online registry to summarize the phenotypic features of 3q29 deletion syndrome (<xref ref-type="bibr" rid="B5">5</xref>). To date, this is the largest cohort of patients with reported clinical data from 44 individuals. However, the data was self-reported/reported by family members and does not show deletion sizes to enable genotype-phenotype correlation. Authors highlighted the large clinical variability. Nonetheless, 64% of patients had a low birth weight and feeding problems, while ~30% of cases had neuropsychiatric disorders (anxiety, panic attacks, depression or bipolar disorder, and schizophrenia). The present case showed various anxieties already present at an early age. The patients in the registry also associated organ abnormalities. Cardiac defects were reported in 26% of cases, with the most frequently defect reported as ductus arteriosus and ventricular septal defect, a rare condition, reported only in two other cases (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B14">14</xref>). The registry reported a high prevalence of gastrointestinal disorders (68%). In the present case constipation was one of the major issues for the family. The present case had rare clinical features (<xref ref-type="table" rid="T1">Table 1</xref>), reported in &lt;20% of cases, such as large protruding ears (9%) and long philtrum (9%). Conversely, features frequently reported (in more than 40% of cases) were not identified, such as a high nasal bridge or long narrow face, however, these features could change with age.</p>
<p>The deleted region of the presented patient partly overlaps the canonical 3q29 deletion, associating a different facial phenotype compared to the classic 3q29 deletion, nonetheless showing a similar psychiatric disorder (<xref ref-type="fig" rid="F1">Figure 1</xref>). <italic>PAK2</italic> and <italic>DLG1</italic> are autosomal homologs of the X-linked intellectual disability genes <italic>PAK3</italic> and <italic>DLG3</italic>. Haplosufficiency of <italic>PAK3</italic> or <italic>DLG3</italic> was previously associated with intellectual disability (<xref ref-type="bibr" rid="B14">14</xref>). Importantly, several transcription factors are mapped within this region, however their role in development is not completely understood. The patient reported by Krepischi-Santos et al. (<xref ref-type="bibr" rid="B15">15</xref>) had moderate intellectual disability and a particular phenotype caused by a small deletion of 1.0 Mb on the 3q29 chromosome, including gene <italic>DIG1</italic> (OMIM <ext-link ext-link-type="Omim" xlink:href="601014">601014</ext-link>) (<xref ref-type="bibr" rid="B5">5</xref>). Cobb's case, described in 2010 (<xref ref-type="bibr" rid="B8">8</xref>) was a 6 years old boy with a particular phenotype, autism spectrum disorders and ADHD but no intellectual disability, although the deleted region included morbid genes previously associated with intellectual disability (<italic>DLG1</italic> and <italic>PAK2</italic>) (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Out of the 11 non-morbid genes included in the deleted region of the patient, four (<italic>TNK2, UBXN7, SLC51A, and FBX045)</italic> have expressions in the brain. <italic>TNK2</italic> was reported (<xref ref-type="bibr" rid="B16">16</xref>), in a small family with autosomal recessive (AR), infantile onset epilepsy and intellectual disability. Functional studies were performed for the homozygous variant identified. Although our patient did not show seizures, this gene could potentially be considered relevant for the phenotype. The <italic>SLC51A</italic> gene was found to have a potential role of the organic solute transporter in brain dehydroepiandrosterone sulfate/pregnenolone sulfate homeostasis. This transporter was localized especially in steroidogenic cells of the cerebellum and hippocampus. The impact of transporters on neurosteroid homeostasis is poorly understood (<xref ref-type="bibr" rid="B17">17</xref>). The <italic>UBXN7</italic> gene was shown to be expressed in the brain, however its role is poorly understood at the moment (<xref ref-type="bibr" rid="B18">18</xref>). <italic>FBX045</italic> was suggested as a candidate gene for the neuropsychiatric phenotype by [Quintero-Rivera et al. (<xref ref-type="bibr" rid="B2">2</xref>)]. The <italic>FBXO45</italic> gene was also considered as a prominent candidate for mediating schizophrenia pathogenesis (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>), as the ubiquitin ligase F-box protein 45 is critical for synaptogenesis, neuronal migration, and synaptic transmission. While a genome-wide association study of coping behaviors suggests that FBXO45 is associated with emotional expression (<xref ref-type="bibr" rid="B21">21</xref>). Compared with other patient's deletion size and region involved in <xref ref-type="fig" rid="F3">Figure 3</xref>, the closest is patient 3, described by [Dasouki et al. (<xref ref-type="bibr" rid="B9">9</xref>)], however patient phenotypic data was not available to the authors, except for the developmental delay and heart murmur, similar to our patient.</p>
<p>The function of the non-morbid <italic>ZDHHC19, SMCO1, WDR53</italic>, and <italic>PIGX</italic> genes is unclear or not relevant for the phenotype. Interestingly, the <italic>NRROS, TM4SF19 (non-morbid), RNF168</italic>, and <italic>TFRC (morbid, AR)</italic> genes were found to be related to the immune system, yet there were no apparent immune disfunctions in our patient or in the literature.</p>
<p>An Italian group (<xref ref-type="bibr" rid="B12">12</xref>) reported a 1.36 Mb deletion of the 3q arm, 193,046,853–194,407,385, outside of the known specific region for the classical 3q29 deletion syndrome, inherited from the mother and reported in several siblings, presenting with gastroesophageal reflux and milk protein intolerance as first clinical symptoms, later developing mild intellectual disability and endocrinological abnormalities. An overarching characteristic, described by Biamino was overweight, which was also observed in our patient. However, they do not share similar deleted regions. Bioamino et al. (<xref ref-type="bibr" rid="B12">12</xref>) suggested that the <italic>HES1</italic> gene could be causative for the obesity phenotype, while in our patient the <italic>CEP19</italic> gene (associated with Morbid obesity and spermatogenic failure-AR) in haploinsufficiency could play a potential role in our patient.</p>
<p>Aside from <italic>CEP19</italic>, other AR genes in the deleted region of the patient were: <italic>TFRC</italic>, associated with immunodeficiency 46 (OMIM <ext-link ext-link-type="Omim" xlink:href="616740">616740</ext-link>), <italic>PCYT1A</italic>, associated with Spondylometaphyseal dysplasia with cone-rod dystrophy (OMIM <ext-link ext-link-type="Omim" xlink:href="608940">608940</ext-link>), <italic>TCTEX1D2</italic>, associated with Short-rib thoracic dysplasia 17 with or without polydactyly (OMIM <ext-link ext-link-type="Omim" xlink:href="617405">617405</ext-link>), and <italic>RNF168</italic>, associated with RIDDLE syndrome (OMIM <ext-link ext-link-type="Omim" xlink:href="611943">611943</ext-link>). Considering the lack of association between patient phenotype and the symptoms of the associated pathology, these genes were not considered relevant for the phenotype.</p>
<p>The reported case provides additional clinical and molecular features that complete the phenotype and genotype of 3q29 Deletion syndrome.</p>
<p>A second hypothesis was considered for this particular case, however, the other CNVs observed in the SNP array analysis were benign. Also, the parental study showed <italic>de novo</italic> deletion 3q29. These arguments are supportive for the phenotype-genotype correlation. Nonetheless, the possibility of a second event, at the molecular level, cannot be excluded.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>We present the phenotype correlated with the smallest reported <italic>de novo</italic> chromosome 3q29 deletion (&lt;1 Mb) in a patient with microcephaly, full moon face, flat profile, global developmental delay, aggressive behavior, and ventricular septal defect. This deletion is different from the canonical 3q29 deleted region, as it does not include the <italic>PAK2</italic> and <italic>DLG1</italic> genes, considered as candidates for causing intellectual disability, thus, narrowing the genotype-phenotype correlation for the region. <italic>FBX045</italic> is suggested as a candidate gene for the neuropsychiatric phenotype.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data Availability</title>
<p>This manuscript contains previously unpublished data. The name of the repository and accession number are not available.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The parents provided the written informed consent to publish this case (including publication of images).</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>AC, AD, CP, MP, and SA contributed to patient clinical and genetic evaluation and the writing process. GD contributed to patient cardiological evaluation and the writing process. CH and DM contributed to patient genetic evaluation and the writing process.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We thank the family for their collaboration and trust.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The research was performed in the Center of Genomic Medicine from the Victor Babes University of Medicine and Pharmacy of Timisoara, POSCCE Project ID: 1854, cod SMIS: 48749, contract 677/09.04.2015. The funding agency for the above-mentioned project, ANCS had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>E</given-names></name><name><surname>Piccini</surname><given-names>F</given-names></name><name><surname>Zollino</surname><given-names>M</given-names></name><name><surname>Neri</surname><given-names>G</given-names></name><name><surname>Caselli</surname><given-names>D</given-names></name><name><surname>Tenconi</surname><given-names>R</given-names></name><etal></etal></person-group>. <article-title>Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations</article-title>. <source/>J Med Genet. (<year>2001</year>) <volume>38</volume>:<fpage>417</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.6.417</pub-id><pub-id pub-id-type="pmid">11424927</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintero-Rivera</surname><given-names>F</given-names></name><name><surname>Sharifi-Hannauer</surname><given-names>P</given-names></name><name><surname>Martinez-Agosto</surname><given-names>JA</given-names></name></person-group>. <article-title>Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review</article-title>. <source/>Am J Med Genet A. (<year>2010</year>) <volume>152A</volume>:<fpage>2459</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33573</pub-id><pub-id pub-id-type="pmid">20830797</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willatt</surname><given-names>L</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Barber</surname><given-names>J</given-names></name><name><surname>Cabanas</surname><given-names>ED</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Donnai</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome</article-title>. <source/>Am J Hum Genet. (<year>2005</year>) <volume>77</volume>:<fpage>154</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1086/431653</pub-id><pub-id pub-id-type="pmid">15918153</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>EK</given-names></name><name><surname>Rees</surname><given-names>E</given-names></name><name><surname>Walters</surname><given-names>JTR</given-names></name><name><surname>Smith</surname><given-names>K-G</given-names></name><name><surname>Forty</surname><given-names>L</given-names></name><name><surname>Grozeva</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Copy number variation in bipolar disorder</article-title>. <source/>Mol Psychiatry. (<year>2016</year>) <volume>21</volume>:<fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.174</pub-id><pub-id pub-id-type="pmid">25560756</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glassford</surname><given-names>MR</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Freedman</surname><given-names>AA</given-names></name><name><surname>Zwick</surname><given-names>ME</given-names></name><name><surname>Mulle</surname><given-names>JG</given-names></name></person-group>
<article-title>Novel features of 3q29 deletion syndrome: results from the 3q29 registry</article-title>. <source/>Am J Med Genet A. (<year>2016</year>) <volume>170</volume>:<fpage>999</fpage>–<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37537</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>DM</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name></person-group>. <article-title>A clinical case report and literature review of the 3q29 microdeletion syndrome</article-title>. <source/>Clin Dysmorphol. (<year>2015</year>) <volume>24</volume>:<fpage>89</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1097/MCD.0000000000000077</pub-id><pub-id pub-id-type="pmid">25714563</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digilio</surname><given-names>MC</given-names></name><name><surname>Bernardini</surname><given-names>L</given-names></name><name><surname>Mingarelli</surname><given-names>R</given-names></name><name><surname>Capolino</surname><given-names>R</given-names></name><name><surname>Capalbo</surname><given-names>A</given-names></name><name><surname>Giuffrida</surname><given-names>MG</given-names></name><etal></etal></person-group>. <article-title>3q29 Microdeletion: a mental retardation disorder unassociated with a recognizable phenotype in two mother–daughter pairs</article-title>. <source/>Am J Med Genet A. (<year>2009</year>) <volume>149A</volume>:<fpage>1777</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.32965</pub-id><pub-id pub-id-type="pmid">19610115</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>W</given-names></name><name><surname>Anderson</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>C</given-names></name><name><surname>Hoffman</surname><given-names>RD</given-names></name><name><surname>Schonberg</surname><given-names>S</given-names></name><name><surname>Levin</surname><given-names>SW</given-names></name></person-group>. <article-title>1.3 Mb <italic>de novo</italic> deletion in chromosome band 3q29 associated with normal intelligence in a child</article-title>. <source/>Eur J Med Genet. (<year>2010</year>) <volume>53</volume>:<fpage>415</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2010.08.009</pub-id><pub-id pub-id-type="pmid">20832509</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasouki</surname><given-names>M.J.</given-names></name><name><surname>Lushington</surname><given-names>G. H.</given-names></name><name><surname>Hovanes</surname><given-names>K.</given-names></name><name><surname>Casey</surname><given-names>J.</given-names></name><name><surname>Gorre</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>The 3q29microdeletion syndrome: report of three new unrelated patients and insilico‘RNA binding’analysis of the 3q29 region</article-title>. <source/>Am. J. Med. Genet. A<volume>155A</volume>:<fpage>1654</fpage>–<lpage>1660</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34080</pub-id><pub-id pub-id-type="pmid">21626679</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagar</surname><given-names>A</given-names></name><name><surname>Bishop</surname><given-names>JR</given-names></name><name><surname>Tessman</surname><given-names>DC</given-names></name><name><surname>Guter</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>CL</given-names></name><name><surname>Cook</surname><given-names>EH</given-names></name></person-group>. <article-title>Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion</article-title>. <source/>Am J Med Genet A. (<year>2013</year>) <volume>161A</volume>:<fpage>845</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35754</pub-id><pub-id pub-id-type="pmid">23443968</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Città</surname><given-names>S</given-names></name><name><surname>Buono</surname><given-names>S</given-names></name><name><surname>Greco</surname><given-names>D</given-names></name><name><surname>Barone</surname><given-names>C</given-names></name><name><surname>Alfei</surname><given-names>E</given-names></name><name><surname>Bulgheroni</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients</article-title>. <source/>Am J Med Genet A. (<year>2013</year>) <volume>161A</volume>:<fpage>3018</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36142</pub-id><pub-id pub-id-type="pmid">24214349</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biamino</surname><given-names>E</given-names></name><name><surname>Di Gregorio</surname><given-names>E</given-names></name><name><surname>Belligni</surname><given-names>EF</given-names></name><name><surname>Keller</surname><given-names>R</given-names></name><name><surname>Riberi</surname><given-names>E</given-names></name><name><surname>Gandione</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity</article-title>. <source/>Am J Med Genet Part B Neuropsychiatr Genet. (<year>2016</year>) <volume>171B</volume>:<fpage>290</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32406</pub-id><pub-id pub-id-type="pmid">26620927</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><name><surname>Giblin</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>RA</given-names></name><name><surname>Dunn</surname><given-names>C</given-names></name><name><surname>Willatt</surname><given-names>L</given-names></name></person-group>. <article-title>Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder</article-title>. <source/>Clin Dysmorphol. (<year>2010</year>) <volume>19</volume>:<fpage>128</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1097/MCD.0b013e32833a1e3c</pub-id><pub-id pub-id-type="pmid">20453639</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Lisi</surname><given-names>EC</given-names></name><name><surname>Wohler</surname><given-names>ES</given-names></name><name><surname>Hamosh</surname><given-names>A</given-names></name><name><surname>Batista</surname><given-names>DA</given-names></name></person-group>. <article-title>3q29 interstitial microdeletion syndrome: an inherited case associated with cardiac defect and normal cognition</article-title>. <source/>Eur J Med Genet. (<year>2009</year>) <volume>52</volume>:<fpage>349</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2009.05.001</pub-id><pub-id pub-id-type="pmid">19460468</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krepischi-Santos</surname><given-names>AC</given-names></name><name><surname>Vianna-Morgante</surname><given-names>AM</given-names></name><name><surname>Jehee</surname><given-names>FS</given-names></name><name><surname>Passos-Bueno</surname><given-names>MR</given-names></name><name><surname>Knijnenburg</surname><given-names>J</given-names></name><name><surname>Szuhai</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations</article-title>. <source/>Cytogenet Genome Res. (<year>2006</year>) <volume>115</volume>:<fpage>254</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1159/000095922</pub-id><pub-id pub-id-type="pmid">17124408</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitomi</surname><given-names>Y</given-names></name><name><surname>Heinzen</surname><given-names>EL</given-names></name><name><surname>Donatello</surname><given-names>S</given-names></name><name><surname>Dahl</surname><given-names>H</given-names></name><name><surname>Damiano</surname><given-names>JA</given-names></name><name><surname>McMahon</surname><given-names>JM</given-names></name><etal></etal></person-group>. <article-title>Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy</article-title>. <source/>Ann Neurol. (<year>2013</year>) <volume>74</volume>:<fpage>496</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23934</pub-id><pub-id pub-id-type="pmid">23686771</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grube</surname><given-names>M</given-names></name><name><surname>Hagen</surname><given-names>P</given-names></name><name><surname>Jedlitschky</surname><given-names>G</given-names></name></person-group>. <article-title>Neurosteroid transport in the brain: role of ABC and SLC transporters</article-title>. <source/>Front Pharmacol. (<year>2018</year>) <volume>9</volume>:<fpage>354</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00354</pub-id><pub-id pub-id-type="pmid">29695968</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagase</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Kikuno</surname><given-names>R</given-names></name><name><surname>Miyajima</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Prediction of the coding sequences of unidentified human genes</article-title>. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins <source/>in vitro. DNA Res. (<year>1998</year>)<volume>5</volume>:<fpage>277</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">9872452</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viñas-Jornet</surname><given-names>M</given-names></name><name><surname>Esteba-Castillo</surname><given-names>S</given-names></name><name><surname>Baena</surname><given-names>N</given-names></name><name><surname>Ribas-Vidal</surname><given-names>N</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name></person-group>. <article-title>High incidence of copy number variants in adults with intellectual disability and co-morbid psychiatric disorders</article-title>. <source/>Behav Genet. (<year>2018</year>) <volume>48</volume>:<fpage>323</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-018-9902-6</pub-id><pub-id pub-id-type="pmid">29882083</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Koide</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Kunimoto</surname><given-names>S</given-names></name><name><surname>Yoshimi</surname><given-names>A</given-names></name></person-group>. <article-title>Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia</article-title>. <source/>Schizophr Res. (<year>2014</year>) <volume>157</volume>:<fpage>149</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2014.04.032</pub-id><pub-id pub-id-type="pmid">24878430</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimanoe</surname><given-names>C</given-names></name><name><surname>Hachiya</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Nishida</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Sutoh</surname><given-names>Y</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>A genome-wide association study of coping behaviors suggests FBXO45 is associated with emotional expression</article-title>. <source/>Genes Brain Behav. <volume>18</volume>:<fpage>e12481</fpage>. <pub-id pub-id-type="doi">10.1111/gbb.12481</pub-id><pub-id pub-id-type="pmid">29665250</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>